That's because the DMCB and the rest of the disease management industry crossed over from that faux reality years ago. It still has nightmares about that colorless place of vacuous press releases, empty branding campaigns, superficial white papers, marketing fluff and insipid trade publications. Once it re-entered present time, substantive and credible publications like this began reanimate the population health universe.
Compare that to an ethereal world of press releases like this from another member of the health insurance industry, South Carolina Blue Cross. The release says that 809 PCMH participants showed a 10.4% decrease in admissions and 12.4% fewer ER visits compared "to the same population's previous year." They also "had better control of cholesterol and glucose levels, improved their Body Mass Index and measures of potential kidney damage, as well as had higher rates of recommended eye exams." In addition to the pre-post evaluation, there was also a comparison to a population of "continuously enrolled diabetic patients treated by all other primary care providers" with similar age and gender mix and similar baseline costs. Compared to that group, there were 11% fewer admissions, 36% fewer inpatient days and 32% fewer ER visits.